2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS

The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)

Bibliographic Details
Main Authors:	Alberico L. Catapano, Ian Graham, Guy De Backer, Olov Wiklund, John M. Chapman, Heinz Drexel, Arno V. Hoes, Catriona S. Jennings, Ulf Landmesser, Terje R. Pedersen, Željko Reiner, Gabriele Riccardi, Marja-Riitta Taskinen, Lale Tokgozoglu, W. M. Monique Verschuren, Charalambos Vlachopoulos, David A. Wood, Jose Luis Zamorano, Marie-Therese Cooney
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-06-01
Series:	Российский кардиологический журнал
Subjects:	dyslipidaemias cholesterol triglycerides low-density lipoproteins high-density lipoproteins apolipoprotein b lipoprotein remnants total cardiovascular risk treatment lifestyle drugs adherence
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2317

Similar Items

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
by: Francois Mach, et al.
Published: (2020-06-01)

European guidelines for the treatment of dyslipidaemias: New concepts and future challenges
by: Angela Pirillo, et al.
Published: (2023-10-01)

Dyslipidaemia in ischaemic stroke patients: results from a tertiary care teaching hospital of Pakistan
by: Ali Hassan Mahesar, et al.
Published: (2021-11-01)

Relationship between Disorders of Lipid Profile and Features of Liver Cirrhosis- An Open Prospective and Comparative Analysis of Patients of Stavropol Territory in Russian Federation
by: Temirlan Ruslanovich Dudov, et al.
Published: (2022-06-01)

Dyslipidaemias in the elderly and the very old: gender differences
by: E. V. Tereshina, et al.
Published: (2013-03-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
by: Alberto Zambon
Published: (2020-04-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Prevalence of dyslipidaemia among diabetic patients at the Namibia Institute of Pathology, Windhoek
by: Sylvia N. Alweendo, et al.
Published: (2023-07-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
by: Maria C. de Beer, et al.
Published: (2005-10-01)

High-density lipoproteins : from basic biology to clinical aspects /
by: Fielding, Christopher J.
Published: (2007)

A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
by: Marina Cuchel, et al.
Published: (2017-04-01)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
by: Susan J. Murdoch, et al.
Published: (2002-08-01)

Distribution of Apolipoprotein A1 Polymorphism (G-75A and C+83T) in Patients with Diabetic Foot Ulcers- A Parallel Group Hospital Based Observational Study
by: Rachita Nanda, et al.
Published: (2021-07-01)

Cholesterol Management in Indians: Should We Treat the Targets or Treat the Risk?
by: Jamshed Dalal, et al.
Published: (2018-03-01)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
by: Holly E. Careskey, et al.
Published: (2008-02-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Association of Hypertensive Retinopathy with different serum lipid parameters in patients of Essential Hypertension: A Hospital Based Study
by: Bishwa Nath Adhikari, et al.
Published: (2018-12-01)

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
by: John S. Millar, et al.
Published: (2008-03-01)

Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)

LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans
by: C. Charles Michel, et al.
Published: (2015-01-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Hyperlipoproteinemia in fasting ponies
by: M.D. Morris, et al.
Published: (1972-05-01)

Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature
by: Meral Kayıkçıoğlu, et al.
Published: (2020-07-01)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
by: Lale Tokgözoglu, et al.
Published: (2020-06-01)

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice
by: Myron E. Hinsdale, et al.
Published: (2002-09-01)

National Health Laboratory Service (NHLS) changes the method of LDL-cholesterol calculation in South Africa
by: T Pillay, et al.
Published: (2023-12-01)

Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
by: Hiroshi Yokomichi
Published: (2017-03-01)

Lipoprotein subfraction patterns throughout gestation in The Gambia: changes in subfraction composition and their relationships with infant birth weights
by: Jessica G. Woo, et al.
Published: (2023-02-01)

Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study
by: Piotr Chruściel, et al.
Published: (2019-06-01)

A comparison of anion-exchange and steric-exclusion HPLC assays of mouse plasma lipoproteins
by: Jonathan Neyer, et al.
Published: (2005-08-01)

Association between Egg Consumption and Cholesterol Concentration: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Man-Yun Li, et al.
Published: (2020-07-01)

Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mices⃞
by: Stefan P.J. Dullens, et al.
Published: (2008-04-01)

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population
by: Francisco J. Tinahones, et al.
Published: (2005-03-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
by: Maria Camila Pruper de Freitas, et al.
Published: (2018-10-01)

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency
by: Agnieska Ćwiklińska, et al.
Published: (2018-06-01)

Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis
by: D.R. Witte, et al.
Published: (2004-06-01)